| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 83 | 2018 | 1005 | 8.230 |
Why?
|
| Lidocaine | 43 | 2018 | 545 | 4.620 |
Why?
|
| Endothelin-1 | 19 | 2018 | 297 | 4.430 |
Why?
|
| Bupivacaine | 27 | 2019 | 414 | 3.710 |
Why?
|
| Hyperalgesia | 20 | 2017 | 527 | 3.690 |
Why?
|
| Sciatic Nerve | 55 | 2020 | 627 | 3.510 |
Why?
|
| Pain, Postoperative | 22 | 2019 | 1768 | 3.330 |
Why?
|
| Nerve Block | 28 | 2020 | 717 | 2.480 |
Why?
|
| Sensory Receptor Cells | 11 | 2018 | 509 | 2.050 |
Why?
|
| Pain | 28 | 2018 | 5098 | 1.980 |
Why?
|
| Rats, Sprague-Dawley | 60 | 2020 | 8106 | 1.730 |
Why?
|
| Sodium Channels | 21 | 2015 | 339 | 1.590 |
Why?
|
| Touch | 7 | 2018 | 313 | 1.560 |
Why?
|
| Rats | 87 | 2020 | 23717 | 1.510 |
Why?
|
| Neural Conduction | 30 | 2009 | 442 | 1.410 |
Why?
|
| Anesthesia, Local | 8 | 2018 | 277 | 1.290 |
Why?
|
| Microspheres | 5 | 2015 | 774 | 1.230 |
Why?
|
| Nerve Growth Factor | 4 | 2018 | 156 | 1.210 |
Why?
|
| Analgesics | 8 | 2017 | 1068 | 1.210 |
Why?
|
| Ion Channels | 32 | 2008 | 1043 | 1.180 |
Why?
|
| Thoracotomy | 4 | 2017 | 374 | 1.140 |
Why?
|
| Nociceptors | 11 | 2010 | 460 | 1.130 |
Why?
|
| Pain Measurement | 24 | 2020 | 3576 | 1.120 |
Why?
|
| Neurons, Afferent | 12 | 2010 | 498 | 1.090 |
Why?
|
| Sodium | 40 | 2008 | 1594 | 1.080 |
Why?
|
| Pain Threshold | 10 | 2017 | 606 | 1.070 |
Why?
|
| Saxitoxin | 26 | 2015 | 65 | 1.040 |
Why?
|
| Hindlimb | 8 | 2015 | 513 | 1.040 |
Why?
|
| Receptor, Endothelin A | 9 | 2011 | 55 | 1.000 |
Why?
|
| Sodium Channel Blockers | 10 | 2016 | 171 | 0.970 |
Why?
|
| Skin | 13 | 2015 | 4499 | 0.920 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2016 | 199 | 0.910 |
Why?
|
| TRPV Cation Channels | 4 | 2016 | 244 | 0.850 |
Why?
|
| Animals | 173 | 2020 | 168930 | 0.760 |
Why?
|
| Peripheral Nerves | 5 | 2013 | 490 | 0.740 |
Why?
|
| Receptors, Endothelin | 8 | 2011 | 56 | 0.730 |
Why?
|
| Tachyphylaxis | 4 | 2010 | 54 | 0.680 |
Why?
|
| Veratridine | 7 | 2008 | 23 | 0.670 |
Why?
|
| Peripheral Nervous System Diseases | 5 | 2008 | 713 | 0.660 |
Why?
|
| Scorpion Venoms | 7 | 2004 | 30 | 0.630 |
Why?
|
| Receptors, Bradykinin | 1 | 2018 | 20 | 0.630 |
Why?
|
| Docosahexaenoic Acids | 3 | 2017 | 915 | 0.620 |
Why?
|
| Action Potentials | 44 | 2017 | 1835 | 0.610 |
Why?
|
| Receptor, Endothelin B | 4 | 2014 | 46 | 0.590 |
Why?
|
| Central Nervous System | 3 | 2010 | 1345 | 0.580 |
Why?
|
| Injections, Subcutaneous | 10 | 2018 | 684 | 0.560 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2019 | 314 | 0.560 |
Why?
|
| Receptors, Neurokinin-1 | 3 | 2017 | 133 | 0.560 |
Why?
|
| Physical Stimulation | 7 | 2018 | 514 | 0.540 |
Why?
|
| Medulla Oblongata | 1 | 2017 | 247 | 0.510 |
Why?
|
| Membrane Potentials | 22 | 2009 | 1085 | 0.510 |
Why?
|
| Receptor, trkA | 1 | 2016 | 159 | 0.500 |
Why?
|
| Neurons, Efferent | 1 | 2015 | 81 | 0.490 |
Why?
|
| Behavior, Animal | 16 | 2013 | 1865 | 0.490 |
Why?
|
| Dose-Response Relationship, Drug | 26 | 2018 | 10745 | 0.480 |
Why?
|
| Epinephrine | 7 | 2009 | 782 | 0.480 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 693 | 0.460 |
Why?
|
| Potassium | 8 | 2009 | 1314 | 0.460 |
Why?
|
| Calcium | 12 | 2015 | 5783 | 0.460 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2014 | 21 | 0.460 |
Why?
|
| Endothelins | 3 | 2011 | 127 | 0.450 |
Why?
|
| Calcium Channels | 5 | 2008 | 622 | 0.450 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 306 | 0.440 |
Why?
|
| Spinal Cord | 3 | 2011 | 1811 | 0.440 |
Why?
|
| Tetrodotoxin | 19 | 2004 | 243 | 0.440 |
Why?
|
| Calcium Channel Blockers | 3 | 2009 | 687 | 0.430 |
Why?
|
| Tetracaine | 3 | 2007 | 34 | 0.410 |
Why?
|
| Hot Temperature | 3 | 2016 | 1442 | 0.410 |
Why?
|
| Orosomucoid | 2 | 2003 | 45 | 0.400 |
Why?
|
| Neurons | 20 | 2017 | 9515 | 0.400 |
Why?
|
| Delayed-Action Preparations | 5 | 2015 | 966 | 0.400 |
Why?
|
| Morphine | 2 | 2015 | 658 | 0.390 |
Why?
|
| Rana pipiens | 20 | 2002 | 64 | 0.370 |
Why?
|
| Nerve Fibers, Myelinated | 15 | 2001 | 951 | 0.370 |
Why?
|
| Surgical Mesh | 1 | 2014 | 315 | 0.370 |
Why?
|
| Progesterone | 1 | 2015 | 752 | 0.360 |
Why?
|
| Capsaicin | 5 | 2011 | 233 | 0.360 |
Why?
|
| Kinetics | 25 | 2013 | 6287 | 0.350 |
Why?
|
| Type C Phospholipases | 1 | 2011 | 287 | 0.350 |
Why?
|
| Diterpenes | 2 | 2008 | 169 | 0.350 |
Why?
|
| Axons | 16 | 2020 | 1675 | 0.350 |
Why?
|
| Ion Channel Gating | 4 | 2002 | 428 | 0.350 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2011 | 148 | 0.340 |
Why?
|
| Ganglia, Spinal | 7 | 2017 | 529 | 0.340 |
Why?
|
| Procaine | 4 | 2004 | 60 | 0.340 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2009 | 3 | 0.330 |
Why?
|
| Nerve Fibers | 15 | 2002 | 706 | 0.330 |
Why?
|
| Anesthesia, Spinal | 5 | 2007 | 280 | 0.330 |
Why?
|
| Time Factors | 25 | 2019 | 40149 | 0.320 |
Why?
|
| Evoked Potentials | 2 | 2015 | 1050 | 0.320 |
Why?
|
| Batrachotoxins | 6 | 1999 | 6 | 0.320 |
Why?
|
| Heart Arrest | 1 | 2019 | 1516 | 0.310 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1999 | 142 | 0.310 |
Why?
|
| Polyradiculopathy | 1 | 2008 | 23 | 0.300 |
Why?
|
| Protein Kinase C | 4 | 2017 | 1206 | 0.300 |
Why?
|
| Analysis of Variance | 7 | 2015 | 6214 | 0.300 |
Why?
|
| Rana catesbeiana | 13 | 2009 | 85 | 0.300 |
Why?
|
| Drug Implants | 4 | 2014 | 230 | 0.300 |
Why?
|
| Membranes, Artificial | 3 | 2007 | 362 | 0.290 |
Why?
|
| Neuralgia | 4 | 2006 | 618 | 0.290 |
Why?
|
| Potassium Channels | 4 | 2003 | 534 | 0.290 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2007 | 26 | 0.290 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2007 | 40 | 0.280 |
Why?
|
| Peripheral Nervous System | 2 | 2007 | 151 | 0.280 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 615 | 0.280 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2013 | 58 | 0.280 |
Why?
|
| Analgesia | 5 | 2020 | 461 | 0.270 |
Why?
|
| Neurosecretory Systems | 1 | 2008 | 223 | 0.270 |
Why?
|
| Male | 70 | 2020 | 364142 | 0.270 |
Why?
|
| Disease Models, Animal | 11 | 2017 | 18330 | 0.270 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2009 | 327 | 0.270 |
Why?
|
| Cytoplasm | 1 | 2011 | 1505 | 0.270 |
Why?
|
| Ions | 1 | 2007 | 254 | 0.260 |
Why?
|
| Motor Neurons | 5 | 2010 | 869 | 0.260 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 371 | 0.260 |
Why?
|
| Cell Membrane | 19 | 2004 | 3641 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2018 | 3459 | 0.240 |
Why?
|
| Ranvier's Nodes | 5 | 1991 | 19 | 0.240 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 903 | 0.230 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 334 | 0.230 |
Why?
|
| Electric Stimulation | 14 | 2002 | 1736 | 0.230 |
Why?
|
| Mollusk Venoms | 3 | 1991 | 19 | 0.230 |
Why?
|
| Receptors, Growth Factor | 2 | 2016 | 324 | 0.230 |
Why?
|
| Hydrogen-Ion Concentration | 16 | 2003 | 2478 | 0.220 |
Why?
|
| Anesthesia | 1 | 2015 | 1595 | 0.220 |
Why?
|
| Anesthesiology | 3 | 2014 | 1137 | 0.220 |
Why?
|
| Amides | 2 | 2003 | 451 | 0.220 |
Why?
|
| Glutamic Acid | 1 | 2009 | 1181 | 0.220 |
Why?
|
| Anesthetics, Inhalation | 3 | 2003 | 573 | 0.210 |
Why?
|
| Injections, Spinal | 2 | 2017 | 317 | 0.210 |
Why?
|
| Hair Follicle | 1 | 2005 | 220 | 0.210 |
Why?
|
| Adrenergic alpha-Agonists | 3 | 2009 | 177 | 0.210 |
Why?
|
| Vasoconstrictor Agents | 3 | 2003 | 654 | 0.210 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 924 | 0.200 |
Why?
|
| Stereoisomerism | 8 | 2002 | 612 | 0.200 |
Why?
|
| Molecular Conformation | 2 | 2002 | 540 | 0.200 |
Why?
|
| Sciatica | 1 | 2002 | 97 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1491 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2018 | 23619 | 0.190 |
Why?
|
| Cells, Cultured | 13 | 2017 | 18984 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1805 | 0.180 |
Why?
|
| Heart | 5 | 2006 | 4425 | 0.180 |
Why?
|
| Substance P | 4 | 2015 | 331 | 0.180 |
Why?
|
| Sodium Bicarbonate | 1 | 2000 | 60 | 0.180 |
Why?
|
| Detergents | 2 | 2004 | 235 | 0.170 |
Why?
|
| Ice | 1 | 2020 | 102 | 0.160 |
Why?
|
| Cryotherapy | 1 | 2020 | 164 | 0.160 |
Why?
|
| Binding, Competitive | 8 | 2004 | 1141 | 0.160 |
Why?
|
| Muscles | 6 | 1986 | 1576 | 0.160 |
Why?
|
| Emulsions | 1 | 2019 | 150 | 0.150 |
Why?
|
| Functional Laterality | 4 | 2010 | 2243 | 0.150 |
Why?
|
| Peptides, Cyclic | 4 | 2010 | 390 | 0.150 |
Why?
|
| Formaldehyde | 2 | 2010 | 360 | 0.150 |
Why?
|
| Binding Sites | 19 | 2004 | 6012 | 0.150 |
Why?
|
| Spinal Nerves | 3 | 2015 | 92 | 0.150 |
Why?
|
| Protein Binding | 3 | 2018 | 9320 | 0.150 |
Why?
|
| Bradykinin | 1 | 2018 | 205 | 0.150 |
Why?
|
| Synaptic Transmission | 4 | 2010 | 1175 | 0.150 |
Why?
|
| Drug Synergism | 8 | 2003 | 1756 | 0.150 |
Why?
|
| Toxins, Biological | 3 | 1987 | 59 | 0.150 |
Why?
|
| Rabbits | 15 | 1999 | 4752 | 0.150 |
Why?
|
| Hair | 2 | 2013 | 508 | 0.150 |
Why?
|
| 4-Aminopyridine | 2 | 2002 | 77 | 0.140 |
Why?
|
| Myelin Sheath | 4 | 2020 | 650 | 0.140 |
Why?
|
| Naloxone | 3 | 2010 | 372 | 0.140 |
Why?
|
| Fluorescent Dyes | 3 | 2003 | 1927 | 0.140 |
Why?
|
| Chemical Phenomena | 6 | 2003 | 485 | 0.140 |
Why?
|
| Electrophysiology | 8 | 2001 | 1263 | 0.140 |
Why?
|
| Vagus Nerve | 6 | 1991 | 458 | 0.140 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 4853 | 0.140 |
Why?
|
| Indole Alkaloids | 1 | 2016 | 23 | 0.140 |
Why?
|
| Pregnancy, Animal | 1 | 1997 | 124 | 0.140 |
Why?
|
| Benzylidene Compounds | 1 | 2016 | 25 | 0.140 |
Why?
|
| Solutions | 5 | 2003 | 405 | 0.130 |
Why?
|
| Tosyl Compounds | 2 | 1987 | 115 | 0.130 |
Why?
|
| Proprioception | 3 | 2003 | 134 | 0.130 |
Why?
|
| Chloride Channels | 2 | 1994 | 221 | 0.130 |
Why?
|
| Foot | 2 | 2010 | 576 | 0.130 |
Why?
|
| Cnidarian Venoms | 2 | 2002 | 19 | 0.130 |
Why?
|
| Anesthesia, Conduction | 1 | 2019 | 264 | 0.130 |
Why?
|
| Cell Line | 5 | 2018 | 15563 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1659 | 0.120 |
Why?
|
| Catastrophization | 1 | 2019 | 352 | 0.120 |
Why?
|
| Oxytocin | 1 | 2019 | 403 | 0.120 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 1377 | 0.120 |
Why?
|
| Drug Interactions | 4 | 2004 | 1419 | 0.120 |
Why?
|
| Affinity Labels | 1 | 1995 | 107 | 0.120 |
Why?
|
| Arthralgia | 1 | 2019 | 459 | 0.120 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 2210 | 0.120 |
Why?
|
| Carbazoles | 1 | 2016 | 230 | 0.120 |
Why?
|
| Azides | 1 | 1995 | 120 | 0.120 |
Why?
|
| Medical Illustration | 1 | 2015 | 134 | 0.120 |
Why?
|
| Injections | 2 | 2020 | 839 | 0.120 |
Why?
|
| Mechanoreceptors | 1 | 1996 | 194 | 0.120 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2015 | 132 | 0.120 |
Why?
|
| Sphingosine | 1 | 2016 | 306 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 946 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2015 | 139 | 0.120 |
Why?
|
| Radiculopathy | 1 | 1996 | 202 | 0.120 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.110 |
Why?
|
| Thermoreceptors | 1 | 1994 | 27 | 0.110 |
Why?
|
| Lipids | 3 | 2019 | 3319 | 0.110 |
Why?
|
| Micelles | 1 | 1994 | 190 | 0.110 |
Why?
|
| Antibody Affinity | 1 | 2014 | 251 | 0.110 |
Why?
|
| Amines | 1 | 2015 | 280 | 0.110 |
Why?
|
| Mastectomy | 2 | 2019 | 1861 | 0.110 |
Why?
|
| Ribs | 1 | 2015 | 257 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4276 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 4400 | 0.110 |
Why?
|
| Afferent Pathways | 2 | 1994 | 303 | 0.110 |
Why?
|
| Astrocytes | 3 | 2014 | 1351 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 724 | 0.110 |
Why?
|
| Neoplasms | 2 | 2015 | 22350 | 0.110 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 490 | 0.100 |
Why?
|
| Guanfacine | 1 | 1993 | 50 | 0.100 |
Why?
|
| Air | 1 | 2013 | 182 | 0.100 |
Why?
|
| Antibody Specificity | 1 | 2014 | 1062 | 0.100 |
Why?
|
| Brain | 10 | 2014 | 27159 | 0.100 |
Why?
|
| Peptides | 4 | 2006 | 4344 | 0.100 |
Why?
|
| Estradiol | 1 | 1999 | 1947 | 0.100 |
Why?
|
| Synaptosomes | 4 | 1995 | 116 | 0.100 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1991 | 31 | 0.100 |
Why?
|
| Clonidine | 1 | 1993 | 170 | 0.100 |
Why?
|
| Adsorption | 2 | 2007 | 198 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 3721 | 0.100 |
Why?
|
| Chemistry, Physical | 3 | 2003 | 152 | 0.100 |
Why?
|
| Methyl Ethers | 2 | 2003 | 196 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2010 | 273 | 0.090 |
Why?
|
| Research Design | 2 | 2004 | 6207 | 0.090 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 250 | 0.090 |
Why?
|
| Amiloride | 1 | 1991 | 116 | 0.090 |
Why?
|
| Structure-Activity Relationship | 7 | 2003 | 3053 | 0.090 |
Why?
|
| Transdermal Patch | 1 | 2011 | 51 | 0.090 |
Why?
|
| Connexins | 1 | 2013 | 355 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2016 | 1079 | 0.090 |
Why?
|
| Thiophenes | 1 | 2015 | 570 | 0.090 |
Why?
|
| Amitriptyline | 1 | 2011 | 110 | 0.090 |
Why?
|
| Bufo marinus | 5 | 1990 | 32 | 0.090 |
Why?
|
| Olfactory Nerve | 5 | 1984 | 21 | 0.090 |
Why?
|
| Inflammation | 2 | 2011 | 10860 | 0.090 |
Why?
|
| Humans | 38 | 2019 | 766766 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 939 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 789 | 0.090 |
Why?
|
| Cesarean Section | 1 | 2019 | 1418 | 0.090 |
Why?
|
| Chloramines | 2 | 1987 | 15 | 0.090 |
Why?
|
| Anesthetics | 2 | 2010 | 525 | 0.090 |
Why?
|
| Arthroplasty | 1 | 2013 | 308 | 0.090 |
Why?
|
| Nephropidae | 4 | 1986 | 70 | 0.090 |
Why?
|
| Ligation | 2 | 2003 | 446 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2008 | 1245 | 0.090 |
Why?
|
| Keratinocytes | 2 | 2013 | 876 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 1889 | 0.080 |
Why?
|
| Narcotic Antagonists | 2 | 2009 | 591 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2003 | 694 | 0.080 |
Why?
|
| Time | 1 | 2011 | 550 | 0.080 |
Why?
|
| Cells | 1 | 2011 | 162 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2677 | 0.080 |
Why?
|
| Nerve Compression Syndromes | 2 | 2003 | 160 | 0.080 |
Why?
|
| Breast | 1 | 2018 | 1971 | 0.080 |
Why?
|
| Nimodipine | 1 | 2009 | 56 | 0.080 |
Why?
|
| Versicans | 1 | 2009 | 40 | 0.080 |
Why?
|
| Veratrine | 3 | 1986 | 6 | 0.080 |
Why?
|
| Fluorescence | 2 | 2007 | 751 | 0.080 |
Why?
|
| Mice | 8 | 2018 | 81889 | 0.080 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2009 | 31 | 0.080 |
Why?
|
| Depression, Chemical | 4 | 1999 | 186 | 0.080 |
Why?
|
| Receptors, Opioid | 1 | 2009 | 145 | 0.080 |
Why?
|
| Cell Size | 2 | 2009 | 625 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1139 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2936 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2351 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2019 | 1251 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2645 | 0.080 |
Why?
|
| Anesthesia, Epidural | 2 | 2007 | 232 | 0.080 |
Why?
|
| Antibodies | 1 | 2016 | 2421 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1389 | 0.080 |
Why?
|
| Myocardium | 4 | 2006 | 4765 | 0.080 |
Why?
|
| Cardiac Glycosides | 1 | 1988 | 29 | 0.070 |
Why?
|
| Electric Conductivity | 6 | 1991 | 405 | 0.070 |
Why?
|
| Reaction Time | 4 | 2006 | 2085 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2014 | 882 | 0.070 |
Why?
|
| Epitopes | 1 | 2014 | 2526 | 0.070 |
Why?
|
| Acetanilides | 1 | 1989 | 168 | 0.070 |
Why?
|
| Chlorides | 1 | 1991 | 666 | 0.070 |
Why?
|
| Reflex | 2 | 2000 | 375 | 0.070 |
Why?
|
| Sandhoff Disease | 1 | 2007 | 14 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 490 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 243 | 0.070 |
Why?
|
| Ethanolamines | 1 | 1988 | 152 | 0.070 |
Why?
|
| Tetraethylammonium | 2 | 2001 | 55 | 0.070 |
Why?
|
| Aeromonas | 1 | 1987 | 17 | 0.070 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 565 | 0.070 |
Why?
|
| Cell Membrane Permeability | 2 | 1988 | 568 | 0.070 |
Why?
|
| Ultrasonic Therapy | 1 | 2009 | 216 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1646 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 243 | 0.070 |
Why?
|
| Hyperesthesia | 1 | 2007 | 23 | 0.070 |
Why?
|
| Lectins | 1 | 2009 | 490 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 439 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5022 | 0.070 |
Why?
|
| Cartilage Diseases | 1 | 2008 | 160 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1991 | 772 | 0.070 |
Why?
|
| Conotoxins | 1 | 1986 | 20 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 2001 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2015 | 2253 | 0.060 |
Why?
|
| Solubility | 5 | 2009 | 1078 | 0.060 |
Why?
|
| Acrylamides | 1 | 1988 | 260 | 0.060 |
Why?
|
| Skin Temperature | 2 | 1997 | 96 | 0.060 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2006 | 147 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1478 | 0.060 |
Why?
|
| Imidazoles | 1 | 2011 | 1168 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2016 | 410 | 0.060 |
Why?
|
| Skin Physiological Phenomena | 2 | 1997 | 193 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 826 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6507 | 0.060 |
Why?
|
| Motor Activity | 3 | 2003 | 2711 | 0.060 |
Why?
|
| Sulfites | 1 | 2004 | 83 | 0.060 |
Why?
|
| Receptors, Tachykinin | 2 | 1994 | 25 | 0.060 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 188 | 0.060 |
Why?
|
| Models, Biological | 8 | 2009 | 9461 | 0.060 |
Why?
|
| Buffers | 3 | 1990 | 141 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2015 | 8307 | 0.060 |
Why?
|
| Ranidae | 2 | 1995 | 32 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2006 | 736 | 0.060 |
Why?
|
| Mathematics | 4 | 1990 | 696 | 0.060 |
Why?
|
| Guanidines | 3 | 1993 | 194 | 0.060 |
Why?
|
| Pharmaceutical Solutions | 1 | 2003 | 15 | 0.060 |
Why?
|
| Isoflurane | 2 | 2002 | 383 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 482 | 0.050 |
Why?
|
| Sodium Chloride | 2 | 1999 | 580 | 0.050 |
Why?
|
| Carbon Dioxide | 2 | 1993 | 1138 | 0.050 |
Why?
|
| Nerve Regeneration | 2 | 2000 | 796 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2693 | 0.050 |
Why?
|
| Spectrophotometry | 2 | 2001 | 291 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 1279 | 0.050 |
Why?
|
| Cell Movement | 1 | 2015 | 5199 | 0.050 |
Why?
|
| Chick Embryo | 3 | 1991 | 972 | 0.050 |
Why?
|
| Pituitary Gland | 2 | 2016 | 635 | 0.050 |
Why?
|
| Neural Inhibition | 2 | 2004 | 589 | 0.050 |
Why?
|
| Microglia | 1 | 2011 | 1370 | 0.050 |
Why?
|
| Surface Properties | 2 | 2003 | 1153 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 1988 | 1188 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2003 | 144 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 18397 | 0.050 |
Why?
|
| Chemistry | 3 | 1987 | 327 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 2228 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2002 | 162 | 0.050 |
Why?
|
| Decapodiformes | 4 | 1987 | 38 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2270 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 1986 | 4924 | 0.050 |
Why?
|
| Benz(a)Anthracenes | 1 | 2001 | 11 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 201 | 0.050 |
Why?
|
| Spinal Nerve Roots | 1 | 2001 | 122 | 0.050 |
Why?
|
| Deuterium | 1 | 1981 | 105 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2201 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 10619 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 2008 | 1104 | 0.050 |
Why?
|
| Administration, Cutaneous | 2 | 2015 | 712 | 0.050 |
Why?
|
| Carbon Radioisotopes | 2 | 1997 | 544 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2000 | 37 | 0.050 |
Why?
|
| Phloretin | 1 | 1980 | 16 | 0.050 |
Why?
|
| Vibrio cholerae | 1 | 1987 | 793 | 0.050 |
Why?
|
| Guanidine | 2 | 1993 | 35 | 0.050 |
Why?
|
| Algorithms | 3 | 2010 | 14072 | 0.050 |
Why?
|
| Sympathomimetics | 1 | 2000 | 56 | 0.040 |
Why?
|
| 1-Octanol | 2 | 2013 | 7 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 8045 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1991 | 2168 | 0.040 |
Why?
|
| Purkinje Fibers | 1 | 1999 | 31 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2888 | 0.040 |
Why?
|
| Female | 18 | 2019 | 396520 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 1995 | 951 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 1885 | 0.040 |
Why?
|
| Receptors, Thyrotropin-Releasing Hormone | 1 | 1999 | 8 | 0.040 |
Why?
|
| Isotonic Solutions | 2 | 1991 | 119 | 0.040 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1999 | 40 | 0.040 |
Why?
|
| Glycosaminoglycans | 2 | 2000 | 611 | 0.040 |
Why?
|
| Octanols | 2 | 1990 | 25 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10445 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1999 | 87 | 0.040 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1999 | 139 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1998 | 67 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9513 | 0.040 |
Why?
|
| Tritium | 5 | 1979 | 707 | 0.040 |
Why?
|
| Nicardipine | 1 | 1998 | 59 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2000 | 299 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11061 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1993 | 7868 | 0.040 |
Why?
|
| Cholesterol | 1 | 2007 | 2903 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13640 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2017 | 187 | 0.040 |
Why?
|
| Sheep | 1 | 2000 | 1448 | 0.040 |
Why?
|
| Anura | 4 | 1981 | 79 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2017 | 340 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2000 | 592 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2006 | 9357 | 0.040 |
Why?
|
| Membranes | 5 | 1993 | 164 | 0.030 |
Why?
|
| Fishes | 3 | 1976 | 607 | 0.030 |
Why?
|
| Cell Separation | 1 | 2002 | 1718 | 0.030 |
Why?
|
| Somatostatin | 1 | 1999 | 459 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 564 | 0.030 |
Why?
|
| Administration, Topical | 1 | 1998 | 702 | 0.030 |
Why?
|
| Ketamine | 1 | 2002 | 527 | 0.030 |
Why?
|
| Tachykinins | 2 | 1994 | 78 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10384 | 0.030 |
Why?
|
| Indoles | 2 | 1994 | 1834 | 0.030 |
Why?
|
| Kidney | 1 | 2011 | 7074 | 0.030 |
Why?
|
| Amphibian Proteins | 2 | 1986 | 35 | 0.030 |
Why?
|
| Clone Cells | 1 | 1998 | 1670 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1976 | 390 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1540 | 0.030 |
Why?
|
| Receptors, Drug | 3 | 1999 | 156 | 0.030 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1994 | 33 | 0.030 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1994 | 59 | 0.030 |
Why?
|
| Neurilemma | 1 | 1974 | 1 | 0.030 |
Why?
|
| Photochemistry | 1 | 1995 | 238 | 0.030 |
Why?
|
| Heating | 1 | 1995 | 103 | 0.030 |
Why?
|
| Piperidines | 3 | 2002 | 1663 | 0.030 |
Why?
|
| Cell Count | 2 | 2000 | 1826 | 0.030 |
Why?
|
| Nifedipine | 1 | 1994 | 220 | 0.030 |
Why?
|
| Tibial Nerve | 1 | 1994 | 55 | 0.030 |
Why?
|
| Collagen | 2 | 2000 | 2635 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 1657 | 0.030 |
Why?
|
| Thermosensing | 1 | 1994 | 56 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2013 | 8 | 0.030 |
Why?
|
| Stilbenes | 1 | 1994 | 155 | 0.030 |
Why?
|
| Microcirculation | 1 | 1998 | 1282 | 0.030 |
Why?
|
| Astacoidea | 1 | 1993 | 14 | 0.030 |
Why?
|
| PC12 Cells | 1 | 1993 | 317 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11920 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1201 | 0.030 |
Why?
|
| Cockroaches | 1 | 1993 | 92 | 0.030 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 1994 | 183 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 1978 | 1007 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1993 | 185 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1622 | 0.030 |
Why?
|
| Permeability | 2 | 1991 | 721 | 0.030 |
Why?
|
| History, 20th Century | 2 | 2014 | 2764 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2015 | 15831 | 0.020 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 3837 | 0.020 |
Why?
|
| Chloroplasts | 1 | 1972 | 46 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 520 | 0.020 |
Why?
|
| Dipeptides | 1 | 1994 | 386 | 0.020 |
Why?
|
| Pyrrolidinones | 1 | 1992 | 116 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2013 | 198 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1993 | 293 | 0.020 |
Why?
|
| Muscle, Smooth | 2 | 1994 | 931 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1972 | 228 | 0.020 |
Why?
|
| Polyethylene Glycols | 2 | 1987 | 1189 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21162 | 0.020 |
Why?
|
| Naphthalenes | 1 | 1992 | 198 | 0.020 |
Why?
|
| Faculty | 1 | 2014 | 383 | 0.020 |
Why?
|
| Neurites | 1 | 1993 | 389 | 0.020 |
Why?
|
| Affect | 1 | 2019 | 1494 | 0.020 |
Why?
|
| Mollusca | 1 | 1991 | 41 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1991 | 305 | 0.020 |
Why?
|
| Carbamates | 1 | 1992 | 191 | 0.020 |
Why?
|
| Guinea Pigs | 4 | 1994 | 1309 | 0.020 |
Why?
|
| Sirolimus | 1 | 2017 | 1540 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2093 | 0.020 |
Why?
|
| Neuroblastoma | 2 | 2001 | 1266 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4142 | 0.020 |
Why?
|
| Pregnancy | 3 | 2019 | 30237 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1995 | 1101 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 21525 | 0.020 |
Why?
|
| Gait | 1 | 1995 | 823 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1990 | 645 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1528 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39309 | 0.020 |
Why?
|
| Sonication | 1 | 2009 | 78 | 0.020 |
Why?
|
| Cell Physiological Phenomena | 1 | 1990 | 149 | 0.020 |
Why?
|
| Iris | 3 | 1994 | 232 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1994 | 1026 | 0.020 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1988 | 23 | 0.020 |
Why?
|
| Benzamides | 1 | 1994 | 1375 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 1494 | 0.020 |
Why?
|
| Avidin | 1 | 1987 | 44 | 0.020 |
Why?
|
| Etidocaine | 1 | 1987 | 3 | 0.020 |
Why?
|
| Rats, Inbred Lew | 2 | 2000 | 1168 | 0.020 |
Why?
|
| Pronase | 1 | 1987 | 28 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 7241 | 0.020 |
Why?
|
| Drosophila melanogaster | 4 | 1986 | 1725 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2008 | 284 | 0.020 |
Why?
|
| Aplysia | 1 | 1987 | 40 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 1987 | 76 | 0.020 |
Why?
|
| Temperature | 2 | 1987 | 2233 | 0.020 |
Why?
|
| Electrophorus | 1 | 1986 | 7 | 0.020 |
Why?
|
| Electric Organ | 1 | 1986 | 55 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1994 | 1457 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2007 | 413 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 1677 | 0.020 |
Why?
|
| Oligopeptides | 2 | 2002 | 1195 | 0.020 |
Why?
|
| Biotin | 1 | 1987 | 255 | 0.020 |
Why?
|
| Microsomes | 1 | 1986 | 252 | 0.020 |
Why?
|
| Epithelium | 1 | 1991 | 1606 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8728 | 0.020 |
Why?
|
| Ligands | 1 | 1993 | 3275 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 6104 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1987 | 240 | 0.020 |
Why?
|
| Nickel | 1 | 1986 | 126 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1987 | 580 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1995 | 3681 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1988 | 479 | 0.020 |
Why?
|
| Muscle Contraction | 3 | 1994 | 1208 | 0.010 |
Why?
|
| Heart Atria | 1 | 1991 | 1361 | 0.010 |
Why?
|
| Glycols | 1 | 1984 | 54 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 13411 | 0.010 |
Why?
|
| Histamine Release | 2 | 1994 | 134 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2013 | 1084 | 0.010 |
Why?
|
| Body Weight | 1 | 1995 | 4626 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 54871 | 0.010 |
Why?
|
| Cations | 1 | 1984 | 239 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1983 | 105 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 17608 | 0.010 |
Why?
|
| beta-Endorphin | 1 | 2003 | 43 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 4340 | 0.010 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2003 | 62 | 0.010 |
Why?
|
| Receptors, Opioid, delta | 1 | 2003 | 48 | 0.010 |
Why?
|
| Scorpions | 1 | 1982 | 4 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1882 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1983 | 292 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 2002 | 50 | 0.010 |
Why?
|
| Colon | 1 | 1991 | 1797 | 0.010 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2003 | 133 | 0.010 |
Why?
|
| Receptors, Opioid, mu | 1 | 2003 | 167 | 0.010 |
Why?
|
| Fura-2 | 1 | 2001 | 107 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1984 | 714 | 0.010 |
Why?
|
| Rana esculenta | 1 | 1981 | 23 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 171343 | 0.010 |
Why?
|
| Fluorometry | 1 | 2001 | 99 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 1981 | 34 | 0.010 |
Why?
|
| Catalysis | 1 | 1983 | 767 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3342 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9346 | 0.010 |
Why?
|
| Bronchi | 1 | 1985 | 847 | 0.010 |
Why?
|
| Genes | 1 | 1985 | 1824 | 0.010 |
Why?
|
| Lithium | 2 | 1974 | 599 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 6307 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15908 | 0.010 |
Why?
|
| Carbon | 1 | 1984 | 673 | 0.010 |
Why?
|
| Axotomy | 1 | 2000 | 71 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 861 | 0.010 |
Why?
|
| Muscle Denervation | 1 | 1980 | 60 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 223257 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 223307 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 71 | 0.010 |
Why?
|
| Barbiturates | 1 | 1980 | 113 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3587 | 0.010 |
Why?
|
| Urodela | 1 | 1979 | 18 | 0.010 |
Why?
|
| Phenols | 1 | 1983 | 526 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14652 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1991 | 3691 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1981 | 354 | 0.010 |
Why?
|
| Diaphragm | 1 | 1980 | 357 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5306 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29948 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 1989 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1979 | 568 | 0.010 |
Why?
|
| Methods | 1 | 1976 | 1065 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2000 | 594 | 0.010 |
Why?
|
| Fishes, Poisonous | 1 | 1974 | 5 | 0.010 |
Why?
|
| Cations, Monovalent | 1 | 1974 | 24 | 0.010 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1994 | 24 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1742 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 9547 | 0.010 |
Why?
|
| Sodium Isotopes | 1 | 1974 | 11 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4207 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1974 | 167 | 0.010 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 1994 | 59 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6779 | 0.010 |
Why?
|
| Thallium | 1 | 1973 | 97 | 0.010 |
Why?
|
| Vas Deferens | 1 | 1994 | 55 | 0.010 |
Why?
|
| Isoindoles | 1 | 1994 | 36 | 0.010 |
Why?
|
| Ouabain | 1 | 1974 | 246 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5143 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59550 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1998 | 2127 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 842 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 5754 | 0.010 |
Why?
|
| Valinomycin | 1 | 1972 | 17 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 1730 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1972 | 73 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1974 | 509 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59939 | 0.010 |
Why?
|
| Seizures | 1 | 1985 | 2996 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2030 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 297 | 0.010 |
Why?
|
| Darkness | 1 | 1972 | 159 | 0.010 |
Why?
|
| Starch | 1 | 1972 | 81 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14471 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 404 | 0.010 |
Why?
|
| Electron Transport | 1 | 1972 | 211 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 655 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 88904 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 8533 | 0.010 |
Why?
|
| Acetates | 1 | 1972 | 314 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 1992 | 376 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2000 | 2976 | 0.010 |
Why?
|
| Aging | 1 | 1988 | 8731 | 0.010 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 1988 | 8 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1992 | 750 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65273 | 0.000 |
Why?
|
| Light | 1 | 1972 | 1358 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4970 | 0.000 |
Why?
|
| Fetus | 1 | 1992 | 1878 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2078 | 0.000 |
Why?
|
| Phenol | 1 | 1983 | 45 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1993 | 2132 | 0.000 |
Why?
|
| Cats | 1 | 1983 | 972 | 0.000 |
Why?
|
| Species Specificity | 1 | 1985 | 2413 | 0.000 |
Why?
|
| Mutation | 1 | 1984 | 30213 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1979 | 526 | 0.000 |
Why?
|
| Larva | 1 | 1980 | 511 | 0.000 |
Why?
|
| Neuromuscular Junction | 1 | 1980 | 399 | 0.000 |
Why?
|
| Genotype | 1 | 1985 | 13036 | 0.000 |
Why?
|
| Synapses | 1 | 1980 | 1759 | 0.000 |
Why?
|